Traws Pharma, Inc.TRAWNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank29
3Y CAGR+13.1%
5Y CAGR-0.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+13.1%/yr
vs -9.3%/yr prior
5Y CAGR
-0.5%/yr
Recent acceleration
Acceleration
+22.4pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.50M | -87.3% |
| 2024 | $130.31M | +1040.1% |
| 2023 | $11.43M | +0.2% |
| 2022 | $11.41M | +56.3% |
| 2021 | $7.30M | -56.8% |
| 2020 | $16.90M | +8.8% |
| 2019 | $15.54M | -7.9% |
| 2018 | $16.87M | -11.4% |
| 2017 | $19.03M | -5.2% |
| 2016 | $20.07M | - |